<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>8k215.htm
<DESCRIPTION>PFIZER INC. 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Pfizer Inc. 8-K </TITLE>
<BODY bgColor=#ffffff>
<DIV align=right> </DIV>
<P align=center><STRONG>UNITED STATES</STRONG></P>
<P align=center><STRONG><FONT size=4>SECURITIES AND EXCHANGE COMMISSION</FONT></STRONG></P>
<P align=center><STRONG>Washington, D.C. 20549</STRONG><br>
[DATA_TABLE_REMOVED_13_LINES]

<BR>
  <strong>(Exact name of registrant as specified in its charter)</strong></P>
<TABLE width="87%" border=0>
  <TR>
    <TD width="43%">
      <DIV align=center><STRONG>Delaware</STRONG></DIV>
    </TD>
    <TD width="25%">
      <DIV align=center><STRONG>1-3619</STRONG></DIV>
    </TD>
    <TD width="32%">
      <DIV align=center><STRONG>13-5315170</STRONG></DIV>
    </TD>
  </TR>
  <TR>
    <TD width="43%">
      <DIV align=center><strong>(State or other Jurisdiction of incorporation)</strong></DIV>
    </TD>
    <TD width="25%">
      <DIV align=center><strong>(Commission File Number)</strong></DIV>
    </TD>
    <TD width="32%">
      <DIV align=center><strong>(I.R.S. Employer Identification No.)</strong></DIV>
    </TD>
  </TR>
  <TR>
    <TD width="43%">
      <BLOCKQUOTE>
        <P align=center><STRONG>235 East 42nd Street <BR>
          New York, New York<BR>
          (Address of principal executive offices)<BR>
          </STRONG></P>
      </BLOCKQUOTE>
    </TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="32%">
      <DIV align=center><STRONG>10017</STRONG><BR>
        <strong>(Zip Code)</strong></DIV>
    </TD>
  </TR>
</TABLE>
<BLOCKQUOTE>
  <BLOCKQUOTE>
    <P align=center> <strong>Registrant's telephone number, including area code: </strong>
    <DIV align=center> <strong>(212) 733-2323 <br>
      <br>
      <u>Not Applicable</u>	<br>
      (Former Name or Former Address, if changed since last report)<br>
    </strong></DIV>
  </BLOCKQUOTE>
</BLOCKQUOTE>
<P align=left>Check the appropriate box below if the Form 8-K filing is intended
  to simultaneously satisfy the obligation of the registrant under any of the
  following provisions: </P>
<P> [&nbsp; &nbsp;] Written communication pursuant to Rule 425 under the Securities
  Act (17 CFR 230.425)</P>
<P> [&nbsp; &nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange
  Act (17 CFR 240.14a-12)</P>
<P> [&nbsp; &nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b)
  under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P> [ &nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c)
  under the Exchange Act (17 CFR 240.13e-4(c))</P>
<P>&nbsp;</P>
<table width="87%" border=0 height="197">
  <tr>
    <td width="13%" height="46"><b>Item 8.01</b></td>
    <td width="87%" height="46"><p><strong>Other Events.</strong></p></td>
  </tr>
  <tr>
    <td height="145" colspan="2">
    <p>On February 9, 2015, Pfizer Inc.  (&ldquo;Pfizer&rdquo;) entered into an accelerated share repurchase agreement with Goldman,  Sachs &amp; Co. (&ldquo;GS&amp;Co.&rdquo;) to repurchase $5 billion of Pfizer&rsquo;s common  stock. Approximately 150 million of the shares to be repurchased under the transaction  will be received by Pfizer on February 11, 2015.</p>
    <p>At settlement of the agreement, which  is expected to occur during or prior to the third quarter of 2015, GS&amp;Co.  may be required to deliver additional shares of common stock to Pfizer, or,  under certain circumstances, Pfizer may be required to deliver shares of its  common stock or may elect to make a cash payment to GS&amp;Co., with the number  of shares to be delivered or the amount of such payment based on the volume-weighted average price of Pfizer&rsquo;s common  stock during the term of the transaction. </p>
    <p>This agreement was entered into  pursuant to Pfizer&rsquo;s previously announced share repurchase authorization.</p>
    <p>The press release relating to the  accelerated share repurchase agreement is filed as an exhibit to this Form 8-K  and is incorporated herein by reference.</p></td>
  </tr>
</table>
<p>&nbsp;</p>
<table width="80%" border=0>
  <tr>
    <td width="21%"><strong>Item 9.01</strong></td>
    <td width="75%"><strong> Financial Statements and Exhibits.</strong></td>
    <td width="4%">&nbsp;</td>
  </tr>
</table>
<table width="80%" border=0>
  <tr>
    <td width="24%">(d) Exhibits<br></td>
    <td width="71%">&nbsp;</td>
    <td width="5%">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td><u>Exhibit No.</u></td>
    <td><u>Description</u></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>Exhibit 99.1</td>
    <td>Press Release of the Company, dated February 9,  2015.</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="24%">&nbsp;</td>
    <td width="71%">&nbsp;</td>
    <td width="5%">&nbsp;</td>
  </tr>
</table>
<p align="left">&nbsp;</p>
<p align="center"><STRONG>SIGNATURE</STRONG></p>
<P>Under the requirements of the Securities Exchange Act of 1934, the registrant
  has caused this report to be signed on its behalf by the authorized undersigned.</P>
<TABLE width="82%" border=0>
  <TR>
    <TD width="33%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="61%">
      <DIV align=left>PFIZER INC.</DIV>
    </TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp; </TD>
  </TR>
  <TR>
    <TD height=41>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
      <DIV align=left>By: <U>/s/ &nbsp;Margaret M. Madden</U><BR>
        Margaret M. Madden</DIV>
    </TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
      <DIV align=left>Title: Vice President and Chief Governance Counsel</DIV></TD>
  </TR>
  <TR>
    <TD>Dated: February 10, 2015</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  </TR>
</TABLE>
<p>&nbsp;</p>
<BLOCKQUOTE>
  <BLOCKQUOTE>
    <BLOCKQUOTE>
      <BLOCKQUOTE>
        <BLOCKQUOTE>
          <BLOCKQUOTE>
            <BLOCKQUOTE>&nbsp;</BLOCKQUOTE>
          </BLOCKQUOTE>
          <p align="left"><b>EXHIBIT INDEX</b></p>
        </BLOCKQUOTE>
      </BLOCKQUOTE>
    </BLOCKQUOTE>
  </BLOCKQUOTE>
</BLOCKQUOTE>
<table width="81%" border=0>
  <tr>
    <td width="17%">
      <p>Exhibit No.</p>
    </td>
    <td width="83%">Description</td>
  </tr>
  <tr>
    <td width="17%">Exhibit 99.1</td>
    <td width="83%">Press Release of the Company, dated February 9,  2015.</td>
  </tr>
</table>
<P align=center>&nbsp;</P>
</TEXT>
</DOCUMENT>